[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2613 followers
Created: 2025-07-18 16:04:40 UTC

$SWTX European Commission conditionally approves EZMEKLY® (mirdametinib) for treating NF1-PN in adult and pediatric patients.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GwJusveWoAA5a29.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946239709015085116/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[$swtx](/topic/$swtx)

[Post Link](https://x.com/OzmosiHealth/status/1946239709015085116)